This is a non-core endpoint: only basic statistics are computed.
See its core counterpart CD2_OTHER_SPECIAL_TNK_LYMPHOMA_EXALLC for full statistics.
Other specified types of T/NK-cell lymphoma, hilmo
CD2_OTHER_SPECIAL_TNK_LYMPHOMA
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
5 |
4. Check minimum number of eventsNone |
5 |
5. Include endpointsNone |
5 |
6. Filter based on genotype QC (FinnGen only) |
5 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Other specified types of T/NK-cell lymphoma, hilmo
based on the number of shared cases.
Similar with more cases:
- Other specified types of T/NK-cell lymphoma, hilmo, excluding all cancers
- Mature T/NK-cell lymphomas, hilmo, excluding all cancers
- Mature T/NK-cell lymphomas, hilmo
- Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)
- Primary_lymphoid and hematopoietic malignant neoplasms
Similar with less cases:
Case counts by codes
↥Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 5 | - | - |
| Unadjusted period prevalence (%) | 0.00 | - | - |
| Median age at first event (years) | 69.98 | - | - |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3023368) Bacteria identified in Blood by Culture
5
12
+∞
2.75
13.4
7.4
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
5
20
+∞
1.82
7.0
4.2
e9/l
0.0
0.0
—
5
20
(3001604) Monocytes [#/volume] in Blood
5
20
+∞
1.82
7.0
4.2
e9/l
0.7
0.7
—
5
20
(3019198) Lymphocytes [#/volume] in Blood
5
20
+∞
1.82
7.0
4.2
e9/l
0.7
1.8
—
5
20
(1761868) Lipid panel - Serum or Plasma
0
20
0.00
0.83
0.0
4.8
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
0
19
0.00
0.82
0.0
2.2
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
0
15
0.00
0.51
0.0
2.7
—
12.5
—
0
9
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
0
17
0.00
0.51
0.0
1.5
—
1.3
—
0
12
(3020682) Albumin/Creatinine [Ratio] in Urine
0
17
0.00
0.51
0.0
3.2
—
1.2
—
0
11
(3029937) Albumin [Presence] in Urine by Test strip
0
14
0.00
0.50
0.0
5.1
—
0.0
—
0
5
(40761511) CBC panel - Blood by Automated count
5
39
+∞
0.24
25.0
19.5
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
5
40
+∞
0.24
29.6
18.3
ml/min/173m2
76.2
79.9
—
5
30
(3021960) Folate [Moles/volume] in Serum or Plasma
0
12
0.00
0.24
0.0
1.2
—
22.8
—
0
7
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
5
41
+∞
0.24
54.0
18.9
mg/l
27.0
19.9
—
5
34
(3002256) Pathology report gross observation
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
0
6
0.00
0.00
0.0
3.2
—
4.6
—
0
6
(3011397) Hemoglobin [Presence] in Urine by Test strip
0
8
0.00
0.00
0.0
5.5
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
5
42
+∞
0.00
50.2
21.0
umol/l
76.6
73.3
—
5
42
(3016502) Oxygen saturation in Arterial blood
0
6
0.00
0.00
0.0
3.2
—
95.9
—
0
6
(3022145) Colonoscopy Study observation
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
0
6
0.00
0.00
0.0
3.2
—
11.8
—
0
6
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_OTHER_SPECIAL_TNK_LYMPHOMA – Other specified types of T/NK-cell lymphoma, hilmo
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).